Loading organizations...
Precision degradation of membrane proteins for autoimmune diseases.
Laigo Bio has raised $19.4M across 2 funding rounds.
Laigo Bio has raised $19.4M in total across 2 funding rounds.
Laigo Bio has raised $19.4M in total across 2 funding rounds.
Laigo Bio's investors include Mariette van der Velden, Thierry Laugel, Lola Buono, Neill Moray Mackenzie, Phil Masterson, Eurazeo, Emil Pot, ROM Utrecht Region, Kurma Partners, Biovance Capital, Joao Incio, MD PhD, Angelini Ventures.
Laigo Bio has raised $19.4M across 2 funding rounds. Most recently, it raised $13.4M Seed in December 2025.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Dec 4, 2025 | $13.4M Seed | Mariette van der Velden, Thierry Laugel | Lola Buono, Neill Moray Mackenzie, Phil Masterson, Eurazeo, Emil Pot, ROM Utrecht Region |
| $6.0M Laigo Bio Seed Extension Mar 2026 | Kurma Partners, Biovance Capital, Joao Incio, MD PhD | Angelini Ventures, ArgoBio, Cancer Research Horizons, Curie Capital, Eurazeo, Oncode Oncology Bridge Fund, ROM Utrecht Region |